Suppr超能文献

佩吉特-施罗特综合征非手术及手术治疗的长期疗效

Long-Term Outcomes of Nonoperative and Surgical Management of Paget-Schroetter Syndrome.

作者信息

Hoexum Frank, Jongkind Vincent, Coveliers Hans M E, Wisselink Willem, Yeung Kak Khee

机构信息

Department of Vascular Surgery, Amsterdam UMC, location VUmc, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

OLV Hospital, Aalst, Belgium.

出版信息

J Endovasc Ther. 2024 Apr;31(2):171-177. doi: 10.1177/15266028221120360. Epub 2022 Sep 8.

Abstract

PURPOSE

In Paget-Schroetter Syndrome (PSS), subclavian vein thrombosis is caused by external compression of the subclavian vein at the costoclavicular junction. Paget-Schroetter Syndrome can be treated nonoperatively, surgically, or with a combination of treatments. Nonoperative management consists, in most cases, of anticoagulation (AC) or catheter-directed thrombolysis (CDT). With surgical management, decompression of the subclavian vein is performed by resection of the first rib. No prospective randomized trials are available to determine whether nonoperative or surgical management is superior. We report our long-term outcomes of both nonoperative and surgically treated patients.

MATERIALS AND METHODS

We retrospectively analyzed all patients with PSS who were treated between January 1990 and December 2015. Patients were divided based on primary nonoperative or primary surgical therapy. Long-term outcomes regarding functional outcomes were assessed by questionnaires using the "Disability of the Arm, Shoulder, and Hand" (DASH) questionnaire, a modified Villalta score, and a disease-specific question regarding lifestyle changes.

RESULTS

In total, 91 patients (95 limbs) were included. Seventy patients (73 limbs) were treated nonoperatively and 21 patients (22 limbs) surgically. Questionnaires were returned by 67 patients (70 limbs). The mean follow-up was 184 months (range, 43-459 months). All functional outcomes were better in the surgical group compared with the nonoperatively treated group (DASH general 3.11 vs 9.86; DASH work 0.35 vs 11.47; DASH sport 5.85 vs 17.98, and modified Villalta score 1.11 vs 3.20 points). Surgically treated patients were more likely to be able to continue their original lifestyle and sports activities (84% vs 40%, p=0.005). Patients with recurrence of thrombosis or the need for surgical intervention after primary nonoperative management reported worse functional outcomes.

CONCLUSION

Surgical management of PSS with immediate CDT followed by first rib resection leads to excellent functional outcomes with low risk of complications. The results of nonoperative management in our non-matched retrospective comparative series were satisfactory, but resulted in worse functional outcomes and more patients needing to adjust their lifestyle compared with surgically treated patients.

CLINICAL IMPACT

Patients with Paget-Schroetter Syndrome and their attending physicians are burdened by the lack of evidence concerning the optimal treatment of this entity. Case series comparing the outcomes of non-operative treatment with surgical treatment are scarce and often not focussed on functional outcomes. Data from this series can aid in the shared decision making after diagnosis of Paget-Schroetter Syndrome. Functional outcomes of non-operative management can be satisfying although high demand patient who are not willing to alter their daily activities are probably better off with surgical management.

摘要

目的

在佩吉特 - 施罗特综合征(PSS)中,锁骨下静脉血栓形成是由锁骨下静脉在肋锁关节处受到外部压迫所致。佩吉特 - 施罗特综合征可采用非手术、手术或综合治疗方法。在大多数情况下,非手术治疗包括抗凝(AC)或导管导向溶栓(CDT)。手术治疗则是通过切除第一肋来解除锁骨下静脉的压迫。目前尚无前瞻性随机试验来确定非手术治疗还是手术治疗更具优势。我们报告了非手术和手术治疗患者的长期预后情况。

材料与方法

我们回顾性分析了1990年1月至2015年12月期间接受治疗的所有PSS患者。患者根据初始非手术或初始手术治疗进行分组。使用“手臂、肩部和手部功能障碍”(DASH)问卷、改良的维拉塔评分以及关于生活方式改变的疾病特异性问题的问卷来评估功能结局方面的长期预后。

结果

总共纳入91例患者(95条肢体)。70例患者(73条肢体)接受非手术治疗,21例患者(22条肢体)接受手术治疗。67例患者(70条肢体)返回了问卷。平均随访时间为184个月(范围43 - 459个月)。与非手术治疗组相比,手术组的所有功能结局均更好(DASH总体评分3.11对9.86;DASH工作评分0.35对11.47;DASH运动评分5.85对17.98,改良维拉塔评分为1.11对3.20分)。接受手术治疗的患者更有可能继续其原来的生活方式和体育活动(84%对40%,p = 0.005)。初始非手术治疗后出现血栓复发或需要手术干预的患者报告的功能结局较差。

结论

PSS的手术治疗采用即时CDT随后切除第一肋可带来极佳的功能结局且并发症风险低。在我们非配对的回顾性比较系列中,非手术治疗的结果令人满意,但与手术治疗的患者相比,其功能结局更差,且更多患者需要调整生活方式。

临床影响

佩吉特 - 施罗特综合征患者及其主治医生因缺乏关于该疾病最佳治疗方法的证据而倍感负担。比较非手术治疗与手术治疗结局的病例系列很少,且往往未聚焦于功能结局。本系列数据有助于在诊断佩吉特 - 施罗特综合征后进行共同决策。非手术治疗的功能结局可能令人满意,尽管对于那些不愿意改变日常活动的高要求患者,手术治疗可能更合适。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25bb/10938484/79faf9e16987/10.1177_15266028221120360-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验